Skip to content
by Legal Desire
SIGN IN GO PRO
10 November 2026

Latham & Watkins Advises Unnatural Products in Sale to argenx for Up to US$1.15 Billion

M&A Healthcare & Life Sciences Announced

Advising firms

Latham & Watkins LLP
Sell-side acting for Unnatural Products, Inc.

Deal team

38 lawyers named
LawyerFirmSeniorityPracticeOffice
Tessa Bernhardt Lead Latham & Watkins LLP Partner M&A Bay Area
Tim Plummer Latham & Watkins LLP Associate M&A Not stated
Kelsey MacKinnon Latham & Watkins LLP Associate M&A Not stated
Alvin Vo Latham & Watkins LLP Associate M&A Not stated
Clyden Pirouzi Latham & Watkins LLP Not stated M&A Not stated
Valentina Oliver Latham & Watkins LLP Not stated M&A Not stated
Alex Kassai Latham & Watkins LLP Partner general corporate matters Bay Area
Christopher Pham Latham & Watkins LLP Associate general corporate matters Not stated
Tori Hu Latham & Watkins LLP Associate general corporate matters Not stated
Grace Lee Latham & Watkins LLP Partner tax matters Bay Area
Tripp Haskins Latham & Watkins LLP Not stated tax matters Not stated
Julie Crisp Latham & Watkins LLP Partner executive compensation and employee benefits matters Los Angeles/San Francisco
Erica Shin Latham & Watkins LLP Associate executive compensation and employee benefits matters Not stated
Nineveh Alkhas Latham & Watkins LLP Partner labor and employment matters Chicago
Alexis Pinzon Latham & Watkins LLP Associate labor and employment matters Not stated
Alyssa Dantoin Latham & Watkins LLP Associate labor and employment matters Not stated
Arielle Singh Latham & Watkins LLP Counsel intellectual property matters Not stated
Robert Yeh Latham & Watkins LLP Counsel intellectual property matters Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy matters Bay Area
Zac Alpert Latham & Watkins LLP Associate data privacy matters Not stated
Sarah Zahedi Latham & Watkins LLP Associate data privacy matters Not stated
Elizabeth Richards Latham & Watkins LLP Partner FDA regulatory matters Washington, D.C.
Chad Jennings Latham & Watkins LLP Counsel FDA regulatory matters Not stated
Betty Pang Latham & Watkins LLP Partner non-FDA healthcare regulatory matters Bay Area
Héctor Armengod Latham & Watkins LLP Partner antitrust matters Brussels
Ian Conner Latham & Watkins LLP Partner antitrust matters Washington, D.C.
Patrick English Latham & Watkins LLP Partner antitrust matters Washington, D.C.
Karen Kim Latham & Watkins LLP Associate antitrust matters Not stated
Juan Pablo Donado Díez Latham & Watkins LLP Associate antitrust matters Not stated
Joseph Cartledge Latham & Watkins LLP Associate antitrust matters Not stated
Dennis Ronel Latham & Watkins LLP Not stated antitrust matters Not stated
James Barker Latham & Watkins LLP Partner regulatory matters Washington, D.C.
Cate Behles Latham & Watkins LLP Counsel regulatory matters Not stated
Ruchi Gill Latham & Watkins LLP Counsel trade controls matters Not stated
Alexander Perkowski Latham & Watkins LLP Associate trade controls matters Not stated
Kevin Chambers Latham & Watkins LLP Partner FCPA matters Washington, D.C.
Hannah Cary Latham & Watkins LLP Counsel representations and warranties insurance matters Not stated
Sandra Mathew Latham & Watkins LLP Associate representations and warranties insurance matters Not stated

35 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 1.15bn (US$1.15 billion)
What the figure measures
Total transaction value
Client
Unnatural Products, Inc.Sell-side
Counterparties
argenx (Buy-side)